EUVIMEDEUVIMED entdecken
Systematische Übersicht

Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy

Yi Ma, Zaiwei Song, Xinya Li, Dan Jiang, Rongsheng Zhao, Zhanmiao Yi iD

Clinical Pharmacokinetics · 2024-03 · 63 (3) · 279-291

DOI: 10.1007/s40262-024-01358-3 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 09.03.2024. Verfasst von Yi Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China. Hauptthemen laut MEDLINE: Rivaroxaban, Polymorphism, Genetic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RivaroxabanPolymorphism, GeneticHumansHemorrhageGenetic TestingAnticoagulants

Substanzen

RivaroxabanAnticoagulants

Autor:innen und Institutionen

  • Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China.
  • Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China.
  • Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, 100191, China.
  • Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
  • Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China. zhaorongsheng@bjmu.edu.cn.
  • Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China. zhaorongsheng@bjmu.edu.cn.

ORCID-Profile: Zhanmiao Yi

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Ma, Y., Song, Z., Li, X., Jiang, D., Zhao, R., & Yi, Z. (2024). Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy. Clinical Pharmacokinetics, 63(3), 279-291. https://doi.org/10.1007/s40262-024-01358-3

Vancouver

Ma Y, Song Z, Li X, Jiang D, Zhao R, Yi Z. Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy. Clinical Pharmacokinetics. 2024;63(3):279-291. doi:10.1007/s40262-024-01358-3

BibTeX
@article{Ma2024,
  author = {Ma, Yi and Song, Zaiwei and Li, Xinya and Jiang, Dan and Zhao, Rongsheng and Yi, Zhanmiao},
  title = {Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy},
  journal = {Clinical Pharmacokinetics},
  year = {2024},
  volume = {63},
  number = {3},
  pages = {279--291},
  doi = {10.1007/s40262-024-01358-3}
}
Kostenlos starten →